Pharmaceutical Technology and Biopharmacy

Phone+31 50 363 3284, +31 50 363 2500

A Deusinglaan1
9713 AV Groningen
Netherlands

Find us here

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

Renate Akkerman
- r.akkerman@umcg.nl
- Faculty of Science and Engineering, Pharmaceutical Technology and Biopharmacy - Onderzoeker
Person: Scientific Staff
Max Beugeling
- M.Beugeling@rug.nl
- Faculty of Science and Engineering, Pharmaceutical Technology and Biopharmacy - Onderzoeker
Person: Scientific Staff
Yoshita Bhide, PhD
- y.c.bhide@umcg.nl
- Faculty of Science and Engineering, Pharmaceutical Technology and Biopharmacy - Onderzoeker
Person: Scientific Staff

Advances in the development of entry inhibitors for sialic-acid-targeting viruses
Heida, R., Bhide, Y. C., Gasbarri, M., Kocabiyik, Ö., Stellacci, F., Huckriede, A. L. W., Hinrichs, W. L. J. & Frijlink, H. W., Jan-2021, In : Drug Discovery Today. 26, 1, p. 122-137 16 p.
Research output: Contribution to journal › Review article › Academic › peer-review

Open Access
Benefits of bacteria-derived exopolysaccharides on gastrointestinal microbiota, immunity and health
Oerlemans, M., Akkerman, R., Ferrari, M., Walvoort, M. & Vos, de, P., Jan-2021, In : Journal of Functional Foods. 76, 14 p., 104289.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

2 Downloads (Pure)
Gene therapy strategies for idiopathic pulmonary fibrosis: Recent advances, current challenges, and future directions
Ruigrok, M. J. R., Frijlink, H. W., Melgert, B. N., Olinga, P. & Hinrichs, W. L. J., Jan-2021, In : Molecular Therapy - Methods & Clinical Development. 20, p. 483-496 14 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

6 Downloads (Pure)

Dataset: Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice
Amssoms, K. (Creator), Born, P. (Creator), Beugeling, M. (Creator), De Clerck, B. (Creator), Van Gulck, E. (Creator), Hinrichs, W. (Creator), Frijlink, E. (Creator), Grasmeijer, N. (Creator), Kraus, G. (Creator), Sutmuller, R. (Creator), Simmen, K. (Creator) & Baert, L. (Creator), University of Groningen, 17-Aug-2018
DOI: 10.6084/m9.figshare.6979778.v1
Dataset

Astellas Foundation 2008-2009
Frijlink, Erik (Recipient), 2008
Prize › Academic
The Utrecht University Award for Excellence in Pharmaceutical Research
Frijlink, Erik (Recipient), 2015
Prize › Academic
Wubbo Ockels Price
Frijlink, Erik (Recipient), 2010
Prize › Academic

10 Participation in conference
8 Talk or presentation
3 Organising an event
2 Editorial activity
More
- 1 Membership of council

PUF Academy
Paul Hagedoorn (Invited speaker)
12-Nov-2020
Activity: Participating in or organising an event › Participation in conference › Professional
PUF Academy
Paul Hagedoorn (Invited speaker)
29-Oct-2020 → 3-Nov-2020
Activity: Participating in or organising an event › Participation in conference › Professional
PUF academy
Paul Hagedoorn (Invited speaker)
5-Mar-2020
Activity: Participating in or organising an event › Participation in conference › Professional

Oplossing voor niet langer leverbare Rhinocort Turbuhaler
Paul Hagedoorn
01/02/2020
1 Media contribution
Press/Media: Public Engagement Activities › Professional
Proefdiervrij moet betrouwbaardere en waardevollere wetenschap opleveren
Henri Leuvenink & Peter Olinga
19/04/2019
1 item of Media coverage
Press/Media: Public Engagement Activities › Professional
UMCG werkt aan vaccin om alle griepen de wereld uit te helpen
H.W. Frijlink
08/03/2018
1 Media contribution
Press/Media: Research › Popular